Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Suggested authors matching "AUTH:Jardin F" with an ORCID

fabrice jardin
Centre Henri Becquerel
27
Publications
725
Citations
View profile

Search results

1-25 of 468 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Real-world data for marginal zone lymphoma patients in the French REALYSA cohort: The REALMA study.
Bommier C, Donzel M, Rossi C, Fornecker LM, Bijou F, Chauchet A, Lebras L, Ysabaert L, Haioun C, Bouabdallah K, Gastinne T, Morineau N, Amorim S, Jardin F, Abraham J, Lamy de la Chapelle T, Gressin R, Fouillet L, Fruchart C, [...] Thieblemont C
Hematol Oncol, 42(6):e3314, 01 Nov 2024
Cited by: 0 articles | PMID: 39351974
Add to export list
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22<sup>+</sup> Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.
Chevallier P, Leguay T, Delord M, Salek C, Kim R, Huguet F, Hicheri Y, Wartiovaara-Kautto U, Raffoux E, Cluzeau T, Balsat M, Roth-Guepin G, Tavernier E, Lepretre S, Bilger K, Bergugnat H, Berceanu A, Alexis M, Doubek M, [...] European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL)
J Clin Oncol, JCO2400490, 17 Oct 2024
Cited by: 0 articles | PMID: 39418626
Add to export list
Correction: Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients.
Alcantara M, Chevrier M, Jardin F, Schmitt A, Houillier C, Oberic L, Chinot O, Morschhauser F, Peyrade F, Houot R, Hoang-Xuan K, Ghesquieres H, Soussain C
J Hematol Oncol, 17(1):98, 19 Oct 2024
Cited by: 0 articles | PMID: 39427203 | PMCID: PMC11490990
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
[PET-scan: a key examination for the extension of Hodgkin's and non-Hodgkin's lymphomas].
Jardin F
Rev Prat, 74(8):923, 01 Oct 2024
Cited by: 0 articles | PMID: 39439341
Add to export list
[Diagnosing malignant lymphoma].
Jardin F
Rev Prat, 74(8):915-921, 01 Oct 2024
Cited by: 0 articles | PMID: 39439339
Add to export list
[Key features of Hodgkin's and non-Hodgkin's lymphomas].
Jardin F
Rev Prat, 74(8):922, 01 Oct 2024
Cited by: 0 articles | PMID: 39439340
Add to export list
Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapy.
Camus V, Houot R, Brisou G, Tessoulin B, Bailly S, Sesques P, Decroocq J, Krzisch D, Oberic L, Lemonnier F, Bouabdallah K, Campidelli A, Tounes L, Abraham J, Herbaux C, Morschhauser F, Damaj GL, Guidez S, Carras S, [...] Jardin F
Blood Adv, 8(20):5371-5381, 01 Oct 2024
Cited by: 0 articles | PMID: 39163620 | PMCID: PMC11568786
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5' RACE.
Camus V, Viennot M, Viailly PJ, Drieux F, Veresezan EL, Bobée V, Rainville V, Bohers E, Sesques P, Haioun C, Durot E, Bayaram M, Rossi C, Martin L, Penther D, Kaltenbach S, Bruneau J, Paillassa J, Tournilhac O, [...] Jardin F
Blood Adv, bloodadvances.2024013723, 18 Sep 2024
Cited by: 0 articles | PMID: 39293080
Add to export list
Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients.
Alcantara M, Chevrier M, Jardin F, Schmitt A, Houillier C, Oberic L, Chinot O, Morschhauser F, Peyrade F, Houot R, Hoang-Xuan K, Ghesquieres H, Soussain C
J Hematol Oncol, 17(1):86, 19 Sep 2024
Cited by: 0 articles | PMID: 39300447 | PMCID: PMC11414093
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
[Nurturing and growing a community of department heads: Act 2 in haematology].
Houot R, Calmettes C, Park S, Pascal L, Peffault de Latour R, Pigneux A, Quinquenel A, Raffoux E, Thieblemont C, Touati M, Trebouet A, Vaida I, Wémeau M, Bastie JN, Bay JO, Cluzeau T, Cornillon J, Damaj G, Deconinck E, [...] Gyan E
Bull Cancer, 111(10):980-986, 11 Sep 2024
Cited by: 1 article | PMID: 39266427
Add to export list
MYC Rearrangement Prediction From LYSA Whole Slide Images in Large B-Cell Lymphoma: A Multicentric Validation of Self-supervised Deep Learning Models.
Syrykh C, Di Proietto V, Brion E, Copie-Bergman C, Jardin F, Dartigues P, Gaulard P, Molina TJ, Briere J, Oberic L, Haioun C, Tilly H, Maussion C, Morel M, Schiratti JB, Laurent C
Mod Pathol, 37(12):100610, 10 Sep 2024
Cited by: 0 articles | PMID: 39265953
Add to export list
Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity.
Moreno-Arciniegas A, García A, Kelm M, D'Amore F, da Silva MG, Sánchez-González J, Sánchez PL, López-Fernández T, Córdoba R, Asteggiano R, Camus V, Smink J, Ferreira A, Kersten MJ, Bolaños N, Escalera N, Pacella E, Gómez-Talavera S, Quesada A, [...] RESILIENCE Trial Investigators
Eur J Heart Fail, 26(10):2213-2222, 30 Aug 2024
Cited by: 1 article | PMID: 39212445
Add to export list
High-dose chemotherapy with autologous haematopoietic stem cell transplantation in patients with isolated vitreoretinal lymphoma: A LOC network study
Mainguy A, Soussain C, Touitou V, Bennedjai A, Kodjikian L, GHESQUIERES H, Damaj G, Gressin R, Ducloyer JB, Chinot O, Vautier A, Chabrot CM, Ahle G, Taillandier L, Marolleau JP, Chauchet A, Jardin F, Cassoux N, Malaise D, [...] Houillier C
Research Square, 08 Aug 2024
Cited by: 0 articles | PPR: PPR892340
Add to export list Preprint v1
Impact of second autologous stem-cell transplantation at relapsed multiple myeloma: A French multicentric real-life study.
André A, Montes L, Roos-Weil D, Frenzel L, Vignon M, Chalopin T, Debureaux PE, Talbot A, Farge A, Jardin F, Belhadj K, Royer B, Marolleau JP, Arnulf B, Morel P, Harel S
Hemasphere, 8(8):e106, 29 Jul 2024
Cited by: 0 articles | PMID: 39081803 | PMCID: PMC11285034
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study.
Iannitto E, Ferrero S, Bommier C, Drandi D, Ferrante M, Bouabdallah K, Carras S, Gini G, Camus V, Mancuso S, Marcheselli L, Ferrari A, Merli M, Tessoulin B, Stelitano C, Beldjord K, Roti G, Jardin F, Castagnari B, [...] Thieblemont C
Haematologica, 109(7):2297-2302, 01 Jul 2024
Cited by: 0 articles | PMID: 38497158
Add to export list
Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Houot R, Bachy E, Cartron G, Gros FX, Morschhauser F, Oberic L, Gastinne T, Feugier P, Duléry R, Thieblemont C, Joris M, Jardin F, Choquet S, Casasnovas O, Brisou G, Cheminant M, Bay JO, Gutierrez FL, Menard C, [...] Lemonnier F
Nat Med, 30(7):2089, 01 Jul 2024
Cited by: 0 articles | PMID: 38745012 | PMCID: PMC11259554
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.
Carras S, Torroja A, Emadali A, Montaut E, Daguindau N, Tempescul A, Moreau A, Tchernonog E, Schmitt A, Houot R, Dartigeas C, Barbieux S, Corm S, Banos A, Fouillet L, Dupuis J, Macro M, Fleury J, Jardin F, [...] Gressin R
Haematologica, 109(6):1857-1865, 01 Jun 2024
Cited by: 0 articles | PMID: 38031755
Add to export list
A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma.
Durand M, Cabaud Gibouin V, Duplomb L, Salmi L, Caillot M, Sola B, Camus V, Jardin F, Garrido C, Jego G
J Exp Clin Cancer Res, 43(1):148, 22 May 2024
Cited by: 0 articles | PMID: 38773631 | PMCID: PMC11110392
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma.
Draye-Carbonnier S, Camus V, Becker S, Tonnelet D, Lévêque E, Zduniak A, Jardin F, Tilly H, Vera P, Decazes P
Sci Rep, 14(1):8033, 05 Apr 2024
Cited by: 1 article | PMID: 38580734 | PMCID: PMC10997640
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Analysis of immunoglobulin/T-cell receptor repertoires by high-throughput RNA sequencing reveals a continuous dynamic of positive clonal selection in follicular lymphoma.
Bobée V, Viennot M, Rainville V, Veresezan L, Drieux F, Viailly PJ, Michel V, Sater V, Lanic MD, Bohers E, Camus V, Tilly H, Jardin F, Ruminy P
Hemasphere, 8(2):e50, 26 Feb 2024
Cited by: 0 articles | PMID: 38435425 | PMCID: PMC10896008
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
IGH 3'RR recombination uncovers a non-germinal center imprint and c-MYC-dependent IGH rearrangement in unmutated chronic lymphocytic leukemia.
Al Jamal I, Parquet M, Guiyedi K, Aoufouchi S, Le Guillou M, Rizzo D, Pollet J, Dupont M, Boulin M, Faumont N, Boutouil H, Jardin F, Ruminy P, El Hamel C, Lerat J, Al Hamaoui S, Makdissy N, Feuillard J, Gachard N, Peron S
Haematologica, 109(2):466-478, 01 Feb 2024
Cited by: 1 article | PMID: 37496419
Add to export list
Correction to: Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B‑cell lymphoma: results of a multicentric prospective cohort study.
Pénichoux J, Lanic H, Thill C, Ménard AL, Camus V, Stamatoullas A, Lemasle E, Leprêtre S, Lenain P, Contentin N, Kraut-Tauzia J, Fruchart C, Kammoun L, Damaj G, Farge A, Delette C, Modzelewski R, Vaudaux S, Pépin LF, [...] Jardin F
Ann Hematol, 103(1):369, 01 Jan 2024
Cited by: 0 articles | PMID: 37880485 | PMCID: PMC10761374
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Artificial intelligence classifies and predicts the outcome of primary CNS and nodal large B-cell lymphomas
Alentorn A, Barillot N, Verdin IH, Rosa LRdl, Velasco R, Drieux F, Veresezan E, Mathon B, Kirasic E, Vidal N, González-Barca E, Esteller FC, López P, Abada Y, Heming M, zu Hörste GM, Grauer O, Garff-Tavernier ML, Davi F, [...] Hoang-Xuan K
Research Square, 22 Dec 2023
Cited by: 0 articles | PPR: PPR777959
Add to export list Preprint v1
Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.
Ghesquières H, Cherblanc F, Belot A, Micon S, Bouabdallah KK, Esnault C, Fornecker LM, Thokagevistk K, Bonjour M, Bijou F, Haioun C, Morineau N, Ysebaert L, Damaj G, Tessoulin B, Guidez S, Morschhauser F, Thiéblemont C, Chauchet A, [...] Camus V
Blood Adv, 8(2):296-308, 01 Jan 2024
Cited by: 0 articles | PMID: 37874913 | PMCID: PMC10824688
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study.
Sarkozy C, Thieblemont C, Oberic L, Moreau A, Bouabdallah K, Damaj G, Gastinne T, Tessoulin B, Ribrag V, Casasnovas O, Haioun C, Houot R, Jardin F, Van Den Neste E, Cheminant M, Morschhauser F, Callanan M, Safar V, Gressin R, [...] Le Gouill S
J Clin Oncol, 42(7):769-773, 18 Dec 2023
Cited by: 0 articles | PMID: 38109684
Add to export list

1-25 of 468 results

1 2 3 Next ...

Search life-sciences literature (45,100,050 articles, preprints and more)

Suggested authors matching "AUTH:Jardin F" with an ORCID

Search results

Real-world data for marginal zone lymphoma patients in the French REALYSA cohort: The REALMA study.

Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22<sup>+</sup> Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.

Correction: Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients.

[PET-scan: a key examination for the extension of Hodgkin's and non-Hodgkin's lymphomas].

[Diagnosing malignant lymphoma].

[Key features of Hodgkin's and non-Hodgkin's lymphomas].

Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapy.

Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5' RACE.

Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients.

[Nurturing and growing a community of department heads: Act 2 in haematology].

MYC Rearrangement Prediction From LYSA Whole Slide Images in Large B-Cell Lymphoma: A Multicentric Validation of Self-supervised Deep Learning Models.

Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity.

High-dose chemotherapy with autologous haematopoietic stem cell transplantation in patients with isolated vitreoretinal lymphoma: A LOC network study

Impact of second autologous stem-cell transplantation at relapsed multiple myeloma: A French multicentric real-life study.

Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study.

Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.

Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.

A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma.

Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma.

Analysis of immunoglobulin/T-cell receptor repertoires by high-throughput RNA sequencing reveals a continuous dynamic of positive clonal selection in follicular lymphoma.

IGH 3'RR recombination uncovers a non-germinal center imprint and c-MYC-dependent IGH rearrangement in unmutated chronic lymphocytic leukemia.

Correction to: Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B‑cell lymphoma: results of a multicentric prospective cohort study.

Artificial intelligence classifies and predicts the outcome of primary CNS and nodal large B-cell lymphomas

Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.

Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study.

Partnerships & funding

Search life-sciences literature (45,100,050 articles, preprints and more)

Suggested authors matching "AUTH:Jardin F" with an ORCID Suggested authors have linked their articles in Europe PMC to their ORCID iD. Up to two suggested authors with a matching surname and initial are shown, ordered by the total number of publications they have in Europe PMC.

Search results

Partnerships & funding

Suggested authors matching "AUTH:Jardin F" with an ORCID